In October of 2012 the Orlando City Council adopted a code provision allowing for a reduction in Transportation Impact Fees for qualifying development sites, to reflect the lessened traffic impacts of a Transit Oriented Development (TOD).
The Developer for the Bio-research Center at Health Village has submitted an application for review and approval as a designated TOD. The project located at 2322 Dade Avenue, in the City's North Transportation Benefit Area, and consists of 145,085 square feet of office space and 2,278 square feet of retail space, as identified in the "design development package", dated 4/16/13.
Based on the qualifying characteristics of the project, City staff shall support a 60% reduction to the Transportation Impact Fee assessment. The attached agreement outlines the qualifying criteria for the fee reduction. Following approval by the City Attorney's Office and the Orlando City Council, a reduced Transportation Impact Fee in the amount of $168,443.62 shall be due, prior to permit issuance.